Madhav V. Dhodapkar, MBBS


Titles and Roles

Professor and Anise McDaniel Brock Chair, Department of Hematology and Medical Oncology
Emory University School of Medicine
Georgia Research Alliance Eminent Scholar in Cancer Innovation
Emory University School of Medicine
Director of Center for Cancer Immunology
Winship Cancer Institute of Emory University
Multiple Myeloma
Bone Marrow and Stem Cell Transplant Center
Research Program
Discovery and Developmental Therapeutics


Madhav V. Dhodapkar, MBBS, is the Anise McDaniel Brock Chair and Georgia Research Alliance Eminent Scholar in Cancer Innovation and Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Dhodapkar serves as director of the Winship Center for Cancer Immunology.

Prior to joining Emory, he served as Chief of Hematology, the Arthur H. and Isabel Bunker Professor of Medicine (Hematology), and Professor of Immunobiology at Yale University School of Medicine. An expert in the treatment of multiple myeloma, he also was co-director of the Cancer Immunology Program within the Yale Cancer Center. Other faculty appointments include Myeloma Institute in Little Rock, Arkansas, Memorial Sloan Kettering Cancer Center in New York, New York, and The Rockefeller University in New York, New York.

A board certified hematologist and medical oncologist, Dr. Dhodapkar specializes in the treatment of multiple myeloma and other hematological malignancies. His primary clinical and scholarly focus is the immuno-biology of myeloma and the development of novel biological approaches to treat cancer.


Dr. Dhodapkar received his Medical Degree from the All India Institute of Medical Sciences in New Delhi. He completed his residency in internal medicine at St. Louis University, and his fellowship in hematology and medical oncology at the Mayo Clinic in Rochester, Minnesota.


Dr. Dhodapkar is credited with helping to define the role of the immune system in controlling early cancer cells. His research focuses on how the immune system regulates the progression from precursor lesions to cancer as well as the mechanisms of treatment sensitivity and resistance to cancer immunotherapy.

  • Below is a listing of current federal grants for the above principal investigator.



Dr. Dhodapkar has authored over 100 scientific publications and is section editor for the Journal of Immunology, and associate editor for Blood.

  • PublicationsPublication Date


Dr. Dhodapkar is a prior recipient of several awards including the National Institutes of Health Director's Transformative Research Award and the National Cancer Institute Outstanding Investigator Award in 2016.

Additional Websites

Cascade Link   TOP